Potential role of soluble ST2 protein in idiopathic nephrotic syndrome recurrence following kidney transplantation

Am J Kidney Dis. 2009 Sep;54(3):522-32. doi: 10.1053/j.ajkd.2009.03.021. Epub 2009 Jun 10.

Abstract

Background: Corticosteroid-resistant idiopathic nephrotic syndrome (INS) recurs rapidly after transplantation in 30% to 50% of transplant recipients, suggesting the presence of 1 or more circulating factors that alter the glomerular filtration barrier. We investigated the possible role in INS recurrence of soluble ST2 (sST2) protein, a marker of T helper type 2 (T(H)2) cells and a factor predicted to be regulated by the transcription factor c-Maf; involvement of sST2 protein would be consistent with the observation that both T(H)2 cells and c-Maf appear to be activated during INS relapse.

Study design: Retrospective observational study.

Setting & participants: Patients with biopsy-proven corticosteroid-resistant INS who had undergone kidney transplantation between September 1983 and April 2007 (n = 71). A control group consisting of proteinuric transplant recipients with kidney failure unrelated to INS (n = 34).

Predictor: Patients who developed INS recurrence after transplantation (n = 31) were compared with those in whom INS did not recur (n = 40) and the control group. Recurrence of INS was defined as urine protein excretion greater than 2 g/d immediately after transplantation that persisted at greater than 1 g/d despite treatment or a kidney graft biopsy showing minimal change glomerulonephritis or focal segmental glomerulosclerosis.

Outcomes & measurements: Urine protein excretion in the 3 groups was 5.0 g/d (range, 1.3 to 10.5), 0.14 g/d (range, 0 to 0.46), and 4.3 g/d (range, 3 to 6.2). The sST2 protein was analyzed both quantitatively and qualitatively in patient sera, and its activity was tested in vitro on a mouse podocyte cell line and in vivo in rats.

Results: sST2 protein levels were significantly increased after transplantation in patients with INS recurrence compared with the 2 other groups (617.5 versus 23 pg/mL; P < 0.001 and 158.5 pg/mL; P < 0.01 respectively). However, patients with recurrence expressed a normal sST2 isoform, and the sST2 protein was unable to induce podocyte injury in vitro or trigger proteinuria in rats.

Limitations: Pretransplantation and posttransplantation sera do not always represent paired samples.

Conclusions: These data suggest that sST2 protein is a marker of INS recurrence that does not seem to be involved in the development of INS.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Animals
  • Biomarkers / blood
  • COS Cells
  • Cell Line, Transformed
  • Child
  • Chlorocebus aethiops
  • Female
  • Humans
  • Interleukin-1 Receptor-Like 1 Protein
  • Kidney Transplantation* / adverse effects
  • Male
  • Mice
  • Middle Aged
  • Nephrotic Syndrome / blood*
  • Nephrotic Syndrome / diagnosis
  • Nephrotic Syndrome / prevention & control
  • Rats
  • Rats, Inbred BUF
  • Rats, Inbred Lew
  • Rats, Sprague-Dawley
  • Receptors, Cell Surface / blood
  • Receptors, Cell Surface / physiology*
  • Retrospective Studies
  • Secondary Prevention
  • Young Adult

Substances

  • Biomarkers
  • IL1RL1 protein, human
  • Interleukin-1 Receptor-Like 1 Protein
  • Receptors, Cell Surface